Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

0.5790
-0.0159-2.67%
Pre-market: 0.59000.0110+1.90%09:16 EDT
Volume:2.92M
Turnover:1.71M
Market Cap:160.96M
PE:-1.16
High:0.6000
Open:0.5905
Low:0.5751
Close:0.5949
52wk High:2.55
52wk Low:0.5261
Shares:278.00M
Float Shares:245.00M
Volume Ratio:0.49
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4975
EPS(LYR):-0.2582
ROE:-547.87%
ROA:-49.87%
PB:5.15
PE(LYR):-2.24

Loading ...

Humacyte Q2 Basic EPS USD -0.16

THOMSON REUTERS
·
Aug 12

Humacyte Q2 Operating Expenses USD 27.402 Million

THOMSON REUTERS
·
Aug 12

Humacyte Q2 Revenue USD 406 Thousand VS. Ibes Estimate USD 1.12 Million

THOMSON REUTERS
·
Aug 12

Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 12

Humacyte Inc Expected to Post a Loss of 10 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Humacyte Inc Expected to Post a Loss of 10 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Humacyte Updates Financial Calendar, Sets Quarterly Results Webcast and Call

Reuters
·
Aug 07

Humacyte Gets NASDAQ Notice After Shares Trade Below $1 Bid-price Minimum

Reuters
·
Aug 01

Humacyte Price Target Maintained with a $2.00/Share by BTIG

Dow Jones
·
Jul 29

Humacyte Says FDA Accepts IND for First-in-human CTEV CABG Study

Reuters
·
Jul 27

Humacyte Announces FDA Acceptance of Ind for First-in-Human Clinical Study of Ctev for Coronary Artery Bypass Grafting

THOMSON REUTERS
·
Jul 27

Humacyte - to Initiate Phase 2a Ctev Study in Cabg This Quarter

THOMSON REUTERS
·
Jul 27

Humacyte Names Nephrologists Kossmann, Roy-chaudhury as Dialysis Access Advisors

Reuters
·
Jul 14

BTIG Remains a Buy on Humacyte (HUMA)

TIPRANKS
·
Jun 24

Piper Sandler Sticks to Its Hold Rating for Humacyte (HUMA)

TIPRANKS
·
Jun 18

Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Qiagen (QGEN)

TIPRANKS
·
Jun 17

U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower

Reuters
·
Jun 17

Humacyte Inc : TD Cowen Cuts Target Price to $1.25 From $1.5

THOMSON REUTERS
·
Jun 17

Humacyte Price Target Maintained With a $2.00/Share by BTIG

Dow Jones
·
Jun 16

Humacyte says Phase 3 study shows bioengineered ATEV blood vessel beats AV fistula in women on dialysis

Reuters
·
Jun 15